JBC Transcription and Nuclear Factor Monoclonals

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M312710200 on April 15, 2004

J. Biol. Chem., Vol. 279, Issue 24, 25333-25338, June 11, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/24/25333    most recent
M312710200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pitsi, D.
Right arrow Articles by Octave, J.-N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pitsi, D.
Right arrow Articles by Octave, J.-N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Presenilin 1 Stabilizes the C-terminal Fragment of the Amyloid Precursor Protein Independently of {gamma}-Secretase Activity*

Didier Pitsi and Jean-Noël Octave{ddagger}

From the Laboratoire de Pharmacologie Expérimentale, Université Catholique de Louvain, 1200 Brussels, Belgium

The cleavage of the transmembrane amyloid precursor protein (APP) by {beta}-secretase leaves the C-terminal fragment of APP, C99, anchored in the plasma membrane. C99 is subsequently processed by {gamma}-secretase, an unusual aspartyl protease activity largely dependent on presenilin (PS), generating the amyloid {beta}-peptide (A{beta}) that accumulates in the brain of patients with Alzheimer's disease. It has been suggested that PS proteins are the catalytic core of this proteolytic activity, but a number of other proteins mandatory for {gamma}-secretase cleavage have also been discovered. The exact role of PS in the {gamma}-secretase activity remains a matter of debate, because cells devoid of PS still produce some forms of A{beta}. Here, we used insect cells expressing C99 to demonstrate that the expression of presenilin 1 (PS1), which binds C99, not only increases the production of A{beta} by these cells but also increases the intracellular levels of C99 to the same extent. Using pulse-chase experiments, we established that this results from an increased half-life of C99 in cells expressing PS1. In Chinese hamster ovary cells producing C99 from full-length human APP, similar results were observed. Finally, we show that a functional inhibitor of {gamma}-secretase does not alter the ability of PS1 to increase the intracellular levels of C99. This finding suggests that the binding of PS1 to C99 does not necessarily lead to its immediate cleavage by {gamma}-secretase, which could be a spatio-temporally regulated or an induced event, and provides biochemical evidence for the existence of a substrate-docking site on PS1.


Received for publication, November 20, 2003 , and in revised form, April 14, 2004.

* This work was supported by the Belgian Fonds pour la Formation à la Recherche dans l'Industrie et dans l'Agriculture, the Patrimoine de la Faculté deMédecine de l'UCL, the Communauté Française de Belgique, Actions de Recherche Concertées, the Belgian Fonds de Recherche Scientifique Médicale, and the Queen Elisabeth Medical Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger} To whom correspondence should be addressed: Université Catholique de Louvain, Laboratoire de Pharmacologie Expérimentale, UCL 54.10, 54 Ave. Hippocrate, 1200 Bruxelles, Belgium. Tel.: 32-2-7649341; Fax: 32-2-7645460; E-mail: octave{at}nchm.ucl.ac.be.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
P. Kienlen-Campard, B. Tasiaux, J. Van Hees, M. Li, S. Huysseune, T. Sato, J. Z. Fei, S. Aimoto, P. J. Courtoy, S. O. Smith, et al.
Amyloidogenic Processing but Not Amyloid Precursor Protein (APP) Intracellular C-terminal Domain Production Requires a Precisely Oriented APP Dimer Assembled by Transmembrane GXXXG Motifs
J. Biol. Chem., March 21, 2008; 283(12): 7733 - 7744.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
K. N. Green, H. Martinez-Coria, H. Khashwji, E. B. Hall, K. A. Yurko-Mauro, L. Ellis, and F. M. LaFerla
Dietary Docosahexaenoic Acid and Docosapentaenoic Acid Ameliorate Amyloid-{beta} and Tau Pathology via a Mechanism Involving Presenilin 1 Levels
J. Neurosci., April 18, 2007; 27(16): 4385 - 4395.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Zhao, M.-Z. Cui, G. Mao, Y. Dong, J. Tan, L. Sun, and X. Xu
{gamma}-Cleavage Is Dependent on {zeta}-Cleavage during the Proteolytic Processing of Amyloid Precursor Protein within Its Transmembrane Domain
J. Biol. Chem., November 11, 2005; 280(45): 37689 - 37697.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.